Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients
Background. Uveal melanoma is characterized by a high frequency of hepatic metastases. For patients with liver metastases, who have a median survival of 5 to 7 months, surgery and systemic conventional chemotherapy have little to offer.
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
February 2001
|
| In: |
International journal of clinical oncology
Year: 2001, Jahrgang: 6, Heft: 1, Pages: 25-28 |
| ISSN: | 1437-7772 |
| DOI: | 10.1007/PL00012075 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/PL00012075 |
| Verfasserangaben: | Gerlinde Egerer, Thomas Lehnert, Regina Max, Helmut Naeher, Ulrich Keilholz, Anthony D. Ho |
| Zusammenfassung: | Background. Uveal melanoma is characterized by a high frequency of hepatic metastases. For patients with liver metastases, who have a median survival of 5 to 7 months, surgery and systemic conventional chemotherapy have little to offer. |
|---|---|
| Beschreibung: | Gesehen am 21.12.2021 |
| Beschreibung: | Online Resource |
| ISSN: | 1437-7772 |
| DOI: | 10.1007/PL00012075 |